(Total Views: 305)
Posted On: 11/23/2020 10:01:19 AM
Post# of 721
$LXRP --- Chris Bunka interview 3 days ago regarding the sale of the beverage division to Hill Street Beverage.
Chris indicates he will complete the animal antiviral studies as well as blood pressure studies. In my opinion, these studies will pave the way for major pharmaceutical developments. If successful, I see Lexaria becoming a biotech pharmaceutical company perhaps as soon as the first half of next year. I also suspect big pharma may come knocking on Lexaria's door once these studies prove the concept of faster, smaller, and more bio-available medication delivery. This is big news for those who can see the whole picture, understand it.
https://www.youtube.com/watch?v=mHthJx3ObGU&a...e=youtu.be
Chris indicates he will complete the animal antiviral studies as well as blood pressure studies. In my opinion, these studies will pave the way for major pharmaceutical developments. If successful, I see Lexaria becoming a biotech pharmaceutical company perhaps as soon as the first half of next year. I also suspect big pharma may come knocking on Lexaria's door once these studies prove the concept of faster, smaller, and more bio-available medication delivery. This is big news for those who can see the whole picture, understand it.
https://www.youtube.com/watch?v=mHthJx3ObGU&a...e=youtu.be
(3)
(0)
